These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8915879)

  • 21. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.
    Chan HL; Hussain M; Lok AS
    Hepatology; 1999 Mar; 29(3):976-84. PubMed ID: 10051506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2002 Oct; 68(2):216-20. PubMed ID: 12210410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplantation for hepatitis B-induced liver disease: long-term outcome and effectiveness of antiviral therapy for prevention of recurrent hepatitis B infection.
    Perrakis A; Förtsch T; Del Medico A; Croner RS; Vassos N; Yedibela S; Lohmüller C; Zopf S; Hohenberger W; Müller V
    Transplant Proc; 2013 Jun; 45(5):1953-6. PubMed ID: 23769081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.
    Ijaz S; Torre F; Tedder RS; Williams R; Naoumov NV
    J Med Virol; 2001 Mar; 63(3):210-6. PubMed ID: 11170059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong association between genotype F and hepatitis B virus (HBV) e antigen-negative variants among HBV-infected argentinean blood donors.
    França PH; González JE; Munné MS; Brandão LH; Gouvea VS; Sablon E; Vanderborght BO
    J Clin Microbiol; 2004 Nov; 42(11):5015-21. PubMed ID: 15528689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
    Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein WO; Neuhaus P; Krüger DH; Neumayer HH
    Transpl Int; 1999; 12(4):283-7. PubMed ID: 10460876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B.
    Laskus T; Rakela J; Steers JL; Wiesner RH; Persing DH
    Gastroenterology; 1994 Dec; 107(6):1774-80. PubMed ID: 7958691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation.
    Nishizono A; Kohno K; Takita-Sonoda Y; Hiraga M; Terao H; Fujioka T; Nasu M; Mifune K
    J Med Virol; 1997 Nov; 53(3):266-72. PubMed ID: 9365894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese.
    Song LH; Duy DN; Binh VQ; Luty AJ; Kremsner PG; Bock CT
    J Viral Hepat; 2005 Mar; 12(2):160-7. PubMed ID: 15720531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
    Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
    World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
    Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.